Softwr

Research · head to head

Medidata Rave vs Suzy

Medidata Rave logo

Medidata Rave

Research

Electronic data capture for regulated clinical trials, sold only through a sales process

From
On request
Rated
-
Full reviewWebsite
Suzy logo

Suzy

Research

Enterprise consumer insights on an owned US panel, resold elsewhere through Cint

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Medidata Rave no pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.; Suzy the proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
  • They diverge on capability: Medidata Rave covers Case report form design, Suzy covers Suzy Insights.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Medidata Rave and Suzy actually diverge.

Attributes where Medidata Rave and Suzy differ
AttributeMedidata RaveSuzy
PlatformsWebWeb, iOS, Android

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Medidata Rave

  • Case report form design
  • Edit checks and queries
  • Part 11 audit trail
  • Rave Lite
  • Coding and safety
  • Platform integrations

Only in Suzy

  • Suzy Insights
  • Suzy Live
  • Suzy Audiences
  • Suzy Speaks
  • Video open ends
  • Advanced methods
  • Data Explorer
  • AI Decision Engine

What people use each for

The jobs each tool is most often brought in to do.

Medidata Rave

  • A sponsor running a registrational Phase III study where inspection readiness and a validated audit trail are non negotiablenot Suzy
  • A biotech that wants its CRO to run data management and benefits from the CRO already having Rave trained staff and templatesnot Suzy
  • A sponsor standardising forms across a programme so that a global library is reused rather than each study being built from scratchnot Suzy
  • A device or Phase IV study where Rave Lite gives the same compliance posture at a lower configuration burdennot Suzy

Suzy

  • A US consumer packaged goods brand that needs concept testing back the same day because a packaging decision is due at the end of the week.not Medidata Rave
  • An insights department running an always-on brand tracker on a US audience without re-commissioning fieldwork every wave.not Medidata Rave
  • A team that wants quant screening followed immediately by moderated qual with the same respondents, rather than two vendors and two timelines.not Medidata Rave
  • A product team testing claims and price sensitivity with MaxDiff and conjoint on a panel they can go back to repeatedly.not Medidata Rave

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Medidata Rave

  • No pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.
  • Cost is dominated by study build rather than licence, and every protocol amendment that changes a form triggers billable rework, so a study with unstable protocols costs far more than the initial quote implied.
  • Configuration requires trained specialists, so most sponsors cannot build a study in house and are dependent on Medidata professional services or a CRO, which lengthens startup.
  • The system assumes a professional clinical data management function; a small sponsor without data managers will not operate it directly and will pay a CRO to do so.
  • Deep use of the wider Medidata platform for randomisation, imaging and patient reported data creates commercial lock in, because moving EDC later means unpicking integrations that were bought as one bundle.

Suzy

  • The proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
  • Customers have asked Suzy to build proprietary panels with native speakers in Germany, France, Japan, India and Brazil, which confirms those do not exist today; multi-market brands need a second vendor and lose the single-source comparison.
  • Reviewers report the panel skews female and millennial and falls short on Gen Z, male and various ethnic segments, and that niche or B2B audiences are hard to reach, so quota fills can be slow or impossible.
  • Reviewers also raise data trust concerns about respondent sourcing and vetting, including one naming bot responses and acquiescence bias, which is the standing risk of any single owned opt-in panel with repeat respondents.
  • Pricing is a sales-led annual commitment reported to run around $88,000 a year at the median with onboarding fees and per-seat charges on top, with no trial, no self-serve and no pay-per-response option, so there is no cheap way to validate fit.
  • Credits are pre-committed monthly against forecast activity with no published overage rate, so under-use is wasted spend and a busy quarter triggers an unbudgeted purchase.
  • Integrations are genuinely thin: there is no public integrations page and no public API documentation, and the only confirmed external data relationship is Cint, so expect to move data by export.

Pricing, plan by plan

Medidata Rave

On request
  • Medidata Rave EDC$undefined/year
    • Priced per study through a sales process
    • Study build and configuration charged separately from licence
    • Mid study amendments generally billable

Suzy

On request
  • Suzy$undefined/year
    • Annual subscription with pre-committed monthly research credits
    • Credit volume set against forecast study activity
    • Onboarding fees and per-seat charges quoted separately

Which should you pick?

Choose Medidata Rave if

  • You need case report form design.
  • You also want edit checks and queries.
Medidata Rave review

Choose Suzy if

  • You need suzy insights.
  • You work on Web, iOS, Android.
  • You also want suzy live.
Suzy review

Questions people ask

Is Medidata Rave or Suzy better?
Neither clearly leads. Medidata Rave starts at On request and Suzy at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Medidata Rave or Suzy?
Medidata Rave starts at On request and Suzy at On request.
Does Medidata Rave or Suzy run on more platforms?
Medidata Rave runs on Web. Suzy runs on Web, iOS, Android.
What is Medidata Rave best used for?
Medidata Rave is most often used for a sponsor running a registrational phase iii study where inspection readiness and a validated audit trail are non negotiable, a biotech that wants its cro to run data management and benefits from the cro already having rave trained staff and templates, a sponsor standardising forms across a programme so that a global library is reused rather than each study being built from scratch, a device or phase iv study where rave lite gives the same compliance posture at a lower configuration burden. Of those, a sponsor running a registrational phase iii study where inspection readiness and a validated audit trail are non negotiable and a biotech that wants its cro to run data management and benefits from the cro already having rave trained staff and templates are not what Suzy is typically brought in for.
What can Medidata Rave do that Suzy cannot?
Medidata Rave covers Case report form design, Edit checks and queries, Part 11 audit trail, Rave Lite. Suzy covers Suzy Insights, Suzy Live, Suzy Audiences, Suzy Speaks.

Answered from the vendors’ own pages

Medidata Rave: Who owns Medidata?

Dassault Systemes, which acquired Medidata in 2019. Rave is sold as part of the Dassault life sciences portfolio.

Suzy: Is the panel global?

No. Crowdtap, the owned panel, is US only. International studies run on Cint supply, which you could contract for directly.

Medidata Rave: How is Rave priced?

Per study, through a sales process. Nothing is published, and study build and amendments are charged separately from the licence.

Suzy: What does it cost?

Nothing is published. Third-party analysis puts the median contract around $88,000 a year with a range roughly $34,000 to $187,500, plus onboarding and per-seat fees.

Medidata Rave: Is Rave validated out of the box?

Medidata supplies validation and qualification documentation, but the sponsor still owns study level user acceptance testing and its own validation evidence.

Suzy: Is there an API?

Nothing public. Suzy publishes no API documentation and no named connectors beyond Cint. Verify any integration requirement in the sales call before committing.

Medidata Rave: What is Rave Lite for?

Lower complexity studies, typically Phase I, Phase IV and medical device, where a full study build is not justified.

Suzy: What changed in April 2026?

Suzy repositioned as an AI Decision Engine with Intelligence and Impact modules, while headcount fell from about 230 to 186. Ask how the roadmap is now split between that and the classic survey and qual products.

Share

Related pages

More on Medidata Rave

More on Suzy

Keep looking

Other head to heads